Dr. Lieping Chen, the United Technologies Corporation Professor in Cancer Research and Professor of Immunobiology, of Dermatology and of Medicine (Medical Oncology) and Co-Director of the Cancer Immunology Program at Yale Cancer Center, is a pioneer in the field of immuno-oncology and his discoveries have led to life-saving drugs for cancer patients. Now, with the support of the Yale Office of Cooperative Research, Dr. Chen has launched a startup—NextCure—that is poised to lead to even more breakthrough treatments.
ABOUT INNOVATION TO IMPACT
“Innovation to Impact” is a video series highlighting leading Yale entrepreneurs who have turned their groundbreaking research and innovative ideas into businesses that have raised $1M or more and are poised to have significant positive impact on human lives. “At Yale we don’t just want to make new things, we want to make things better.” — Peter Salovey, Yale President